Two new grants from the Cancer Prevention and Research Institute of Texas (CPRIT) are advancing lung cancer research at the 91ÊÓƵ, bringing total active CPRIT funding at UH to $11.1 million. A $1.5 million grant supports development of an mRNA-based immunotherapy platform designed to help the immune system recognize and fight tumors that resist current treatments, while a separate $900,000 grant is funding a biochip-based blood test capable of detecting cancer biomarkers from just a few drops of blood plasma.
These new awards join several other active CPRIT-funded projects at UH targeting immunotherapy biomarkers, drug-resistant cancers, smoking cessation, and more. Among them, Qin Feng, associate professor of biology and biochemistry, is using $250,000 in CPRIT funding to develop new treatment options for prostate cancer patients — particularly those resistant to existing therapies.
Read the full article: